Nestle S.a. · SIX:NESN
Nestle — Conference Presentation (November 2006)
20 slides from Nestle's conference presentation, November 2006
Slide 1: Innovation and Renovation: Consumers at the heart of Nestlé's R&D
Presentation Werner Bauer Innovation and Renovation Consumers at the heart of Nestlé's R&D Werner Bauer 1 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 Good morning Ladies and Gentlemen, I am Werner Bauer, Nestlé's Head of Technical, Production and R&D. As such, the subject o
Slide 2: Responsibilities of the CTO
Responsibilities of the CTO Science & 17 Intellectual Regulatory Innovation Research Research & Property Acceleration • Lausanne Development Teams • St Louis Centres Basic Product Intellectual Innovation Accelerate Research in property claims innovation & Packaging management renovation
Slide 3: Nestlé R&D
Nestlé R & D 275 Application 1,300 R&D Investment Markets Groups people CHF Billion 2005 1.50 Suppliers 17 Research & 2004 1.43 Development Centres 2003 1.21 Corporate Biotech 2,400 2002 1.21 people R&D Start-ups 1 2001 1.16 Research Centre 2000 1.04 Universities 1999 0.90 Research Institutes 1998 0
Slide 4: Partnering in Basic Research
Partnering in Basic Research 4 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 Today, we are on a permanent look-out for new ideas. This is why we are increasingly working in open partnership with many of our suppliers, with start-up companies through our venture capital funds,
Slide 5: Innovation runs through the whole company
Innovation runs through the whole company Integrated cross-functional teams Research Development Value-adding, profitable Strategic innovation and renovation Business Units Regulatory Use of global platforms Market Intellectual Relevance to local consumers Research Innovation Property Renova
Slide 6: The Nestlé Innovation Model
The Nestlé Innovation Model What is What do technically consumers possible ? need ? What is commercially achievable ? 6 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 If you look at the Nestlé innovation model, I have largely covered the R&D side. But there are two more aspect
Slide 7: Major Market Trends
Major Market Trends A new premium light ice cream offerring everything that Haagen-Dazs stands for, with no compromise except half the fat A new, first-to-market premium wet dog food Premium created with proprietary new product +8.7% and packaging technology -5.7% Superior value for money chocolate
Slide 8: Popularly Positioned Products
Popularly Positioned Products 7 6 2.5 billion people earn more than 5 1’500 USD per year Billion People 4 Addressing nutrient deficiencies, 3 improving the lives of millions of consumers with relevant and 2 4 billion people nutritious products earn less than 1 1’500 USD per year 0 8 CORPORATE TECHNI
Slide 9: Most consumers see a strong link between food and their health
Most consumers see a strong link between food and their health 9 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 And this brings me to the third leg of the Nestlé innovation model: consumer insight. In all our major markets, it is perfectly obvious that the vast majority of con
Slide 10: Consumer trends
Consumer trends "Natural" • Bio • Organic • Freshness • Natural Nutrition, Health & Wellness • Enhanced • Enriched • Reduced • Invent Liquification • Convenience / On the Go • Wholesome / Fresh • Functional Benefits • Innovation / New Occasions 10 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chair
Slide 11: Nutrition, Health and Wellness
Nutrition, Health and Wellness Nestlé products and brands at each life stage fulfilling different nutritional needs Mainstream Specific nutritional needs Source: AC Nielsen/GNPD Mintel 11 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 All these factors will be central to our i
Slide 12: Adding health to our products
Adding health to our products 12 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 At Nestlé, highly specific nutritional benefits addressing such issues as heart health, cholesterol control and bone strength are usually provided by adding Branded Active Benefits, or BABs, to exi
Slide 13: Adding nutritional value: Branded Active Benefits – Bone Health
Adding nutritional value: Branded Active Benefits Bone Health Bone Mineral Density (% / year) 6 4 Calci-N 2 Placebo 0 8 years old girls (n=150) - Calci-N enriched nutrition versus placebo for 1 year 4 years later : Calci-N group had significant higher bone mineral density – still higher than control
Slide 14: Adding nutritional value: Branded Active Benefits – Lowering Blood Cholesterol
Adding nutritional value: Branded Active Benefits Lowering Blood Cholesterol % Change in Blood LDL-Cholesterol Control 1.2g/day 1.6g/day 0 Inhibits cholesterol absorption inside the intestine -4 Clinical trials have demonstrated efficacy -8 -12 14 CORPORATE TECHNICAL PRODUCTION AND R&D Name of c
Slide 15: Our science helps to optimise nutritional profiles
Our science helps to optimise nutritional profiles 15 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 However, as already mentioned, the nutritional qualities of food are not improved by enrichment alone. Reducing the quantity of certain ingredients can also contribute to nutri
Slide 16: Science Alignment with Consumer Benefit Areas
Science Alignment with Consumer Benefit Areas Health Benefits • Protection • Growth & Development • Digestive comfort • Weight management • Performance • Healthy ageing • Skin Health & Beauty 16 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 I am often asked, particularly in r
Slide 17: Obesity: A major concern in growing number of countries
Obesity: A major concern in growing number of countries By 2015, 1.5 billion people worldwide will be obese or overweight – a rise of 50% from 2005. 17 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairman November 2006 There is no doubt, however, that obesity, a major societal concern in many cou
Slide 18: Metabolic health perspectives in nutrition
Metabolic health perspectives in nutrition Drug intervention nutritional and lifestyle landscape Risk Management Health management Onset of Diagnostic disregulation markers Prognostic markers Changes in pathway dynamics to maintain homeostasis 18 CORPORATE TECHNICAL PRODUCTION AND R&D Name of chairm
Slide 19: Weight Management
Weight Management Personalising nutrition & lifestyle • One-on-one solutions – programme tailored to client's lifestyle – personalised counselling on nutrition & lifestyle – nutritionally balanced, portion- controlled dishes • 600+ branded centres – US & Canada – Australia & New Zealand 19 CORPORATE
Slide 20: Nestlé Nutrition Council
Nestlé Nutrition Council External Members Nestlé Members Nutrition & food safety Dominique Belli MD Werner Bauer PhD (Chairman) policies & general Geneva Children Hospital, CH Executive Vice President guidance Bruce Bistrian MD Richard Laube Harvard Medical School, USA Deputy Executice Vice Presiden